Business Standard

Monday, December 23, 2024 | 03:57 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Zydus launches cheapest remdesivir at Rs 2,800 per 100 mg vial in India

Potential Covid-19 treatment drug launched under brand name Remdac in India

remdesivir, coronavirus, drugs, covid, pharma
Premium

According to Sharvil Patel, managing director of Cadila Healthcare, as the most affordable Remdesivir brand, Remdac will enable patients ot have access to the critical drug in treatment of Covid-19.

Vinay Umarji Ahmedabad
Pharma major Cadila Healthcare (Zydus Cadila) on Thursday announced launch of what is so far India's cheapest remdesivir brand - Remdac at Rs 2800 per 100 mg lyophilized injection vial. 

The will be made available across India through the group’s strong distribution chain reaching out to government and private hospitals treating Covid patients.

According to Sharvil Patel, managing director of Cadila Healthcare, as the most affordable remdesivir brand, Remdac will enable patients ot have access to the critical drug in treatment of Covid-19. 

"Through the course of this pandemic, our efforts have been focussed on supporting people in this healthcare

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in